儿童的Helicobacter pylori感染:要根除还是不应该根除?
Marco Manfredi1, Madhur Ravikumara2
1Pediatric Unit, Maternal and Child Department, Azienda USL-IRCCS di Reggio Emiila, Sant'Anna Hospital, Reggio Emilia, Italy.
Helicobacter
|November 23, 2024
概括
在儿童时期常见的Helicobacter pylori感染是癌症风险. 然而,由于儿童的潜在益处,儿科指南是谨慎的,需要对根除策略进行批判性分析.
科学领域:
- 微生物学 微生物学
- 儿科 儿科 儿科
- 公共卫生 公共卫生
背景情况:
- 杆菌是人类普遍存在的病原体,是在童年时获得的.
- 世界卫生组织将H. pylori分类为第一组致癌物,是胃癌的主要因素.
- 国际成人指南建议根除H. pylori,但儿科指南更保守.
研究的目的:
- 批判性地分析关于儿童H. pylori根除的不同观点.
- 审查关于H. pylori在所有年龄组中的病理作用的证据.
- 检查突出H. pylori在儿科胃外疾病中的潜在保护作用的研究.
主要方法:
- 国际指南和科学研究的文献综述.
- 关于H. pylori在胃和胃外疾病中的作用的证据的批判性分析.
- 成人与儿科治疗建议的比较评估.
主要成果:
- 杆菌感染与胃癌有关,支持成年人的根除.
- 有证据表明,H. pylori在某些儿科胃外疾病中可能具有有益的作用.
- 成人和儿童治疗H. pylori治疗指南之间存在差异.
结论:
- 在儿童中根除H. pylori的决定需要仔细考虑风险和潜在益处.
- 需要进一步的研究,以澄清H. pylori感染及其在儿童群体中的治疗的长期影响.
- 需要采取平衡的方法,权衡癌症风险与儿童潜在的保护作用.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
328
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
328
Peptic Ulcer Disease IV: Management
74
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
74
Gastritis III: Clinical Manifestations and Management
158
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
158
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
89
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
89
Peptic Ulcer Disease V: Surgical Management and Nursing Care
231
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
231
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
356
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
356


